Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer

GV Scagliotti - Seminars in oncology, 2005 - Elsevier
Over the past decade many large randomized trials have been conducted in patients with
locally advanced or metastatic non-small cell lung cancer (NSCLC); however, no single …

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer

GV Scagliotti - Seminars in oncology, 2005 - pubmed.ncbi.nlm.nih.gov
Over the past decade many large randomized trials have been conducted in patients with
locally advanced or metastatic non-small cell lung cancer (NSCLC); however, no single …

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer.

GV Scagliotti - SEMINARS IN ONCOLOGY, 2005 - iris.unito.it
Over the past decade many large randomized trials have been conducted in patients with
locally advanced or metastatic non-small cell lung cancer (NSCLC); however, no single …

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer.

GV Scagliotti - Seminars in Oncology, 2005 - europepmc.org
Over the past decade many large randomized trials have been conducted in patients with
locally advanced or metastatic non-small cell lung cancer (NSCLC); however, no single …

[引用][C] Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer

GV SCAGLIOTTI - Seminars in oncology, 2005 - pascal-francis.inist.fr
Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer

GV Scagliotti - Seminars in Oncology, 2005 - infona.pl
Over the past decade many large randomized trials have been conducted in patients with
locally advanced or metastatic non-small cell lung cancer (NSCLC); however, no single …

[引用][C] Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer

GV SCAGLIOTTI - Seminars in oncology, 2005 - Elsevier